Merck to Acquire Influenza Drug Maker Sidalra in $9.2 Billion Deal

The pharmaceutical giant expands its portfolio with the acquisition of Sidalra, a company specializing in influenza treatments.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Acquisition: A corporate action where one company purchases most or all of another company's shares to gain control of it.
  • Influenza: A contagious respiratory illness caused by influenza viruses, commonly known as the flu.
  • Pharmaceutical Portfolio: The range of medicines, therapies, and drug-related products developed and marketed by a pharmaceutical company.